Skip to main content

Journal of Thrombosis and Thrombolysis

Ausgabe 3/2020

Inhalt (36 Artikel)

Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19

Mario Bautista-Vargas, Fabio Bonilla-Abadía, Carlos A. Cañas

Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case–control study

Matthew Sherwood, Kevin P. Bliden, Leonard Ilkhanoff, Ganesh Venkataraman, Adam Strickberger, Sharam Yazdani, Robert McSwain, Haroon Rashid, Eliano P. Navarese, Tracy Plummer, Wayne Batchelor, Rahul Chaudhary, Udaya S. Tantry, Paul A. Gurbel

COVID-19-associated vasculitis and vasculopathy

Richard C. Becker

Anticipating the long-term cardiovascular effects of COVID-19

Richard C. Becker

Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?

  • Open Access

Patrick Malcolm Siegel, Judith Schmich, Georg Barinov, István Bojti, Christopher Vedecnik, Novita Riani Simanjuntak, Christoph Bode, Martin Moser, Karlheinz Peter, Philipp Diehl

Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients

Estefanía Cantador, Alberto Núñez, Pilar Sobrino, Victoria Espejo, Lucía Fabia, Lydia Vela, Luis de Benito, Javier Botas

Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis

Bilian Yu, Xin Li, Jin Chen, Mingqi Ouyang, Hong Zhang, Xinge Zhao, Liang Tang, Qin Luo, Min Xu, Lizhen Yang, Guxiang Huang, Xianling Liu, Jianjun Tang

Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19

Marina Rieder, Isabella Goller, Maren Jeserich, Niklas Baldus, Luisa Pollmeier, Luisa Wirth, Alexander Supady, Christoph Bode, Hans-Jörg Busch, Bonaventura Schmid, Daniel Duerschmied, Nadine Gauchel, Achim Lother

COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?

Ritwick Mondal, Durjoy Lahiri, Shramana Deb, Deebya Bandyopadhyay, Gourav Shome, Sukanya Sarkar, Sudeb R. Paria, Tirthankar Guha Thakurta, Pratibha Singla, Subhash C. Biswas

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Yan Zhang, Wei Cao, Wei Jiang, Meng Xiao, Yongzhe Li, Ning Tang, Zhengyin Liu, Xiaowei Yan, Yongqiang Zhao, Taisheng Li, Tienan Zhu

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature

Ying-Kiat Tan, Claire Goh, Aloysius S. T. Leow, Paul A. Tambyah, Alicia Ang, Eng-Soo Yap, Tian-Ming Tu, Vijay K. Sharma, Leonard L. L. Yeo, Bernard P. L. Chan, Benjamin Y. Q. Tan

Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore

Prakash R. Paliwal, Benjamin Y. Q. Tan, Aloysius S. T. Leow, Sunny Sibi, Daniel W. P. Chor, Amanda X. Y. Chin, Ying-Wei Yau, Gail B. Cross, Lily Y. H. Wong, Magdalene L. J. Chia, Zhixuan Quak, Christopher Y. K. Chua, David K. K. Tang, Ei The Zune, Jennifer Hung, Yihui Goh, Mingxue Jing, Anil Gopinathan, Cunli Yang, Aftab Ahmad, Deborah X. L. Khoo, Chang-Chuan M. Lee, Raymond C. S. Seet, Vijay K. Sharma, Hock-Luen Teoh, Leonard L. L. Yeo, Bernard P. L. Chan

Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report

Susan Mohammadi, Morteza Abouzaripour, Nastaran Hesam Shariati, Mohammad Bakhtiar Hesam Shariati

Clinical features and efficacy of reperfusion therapy in minor ischemic stroke patients with atrial fibrillation

Eiichi Nomura, Makoto Takemaru, Takahiro Himeno, Ryuhei Kono, Tomoko Fukushima, Shinzo Ota

Intensified P2Y12 inhibition for high-on treatment platelet reactivity

Fakilahyel S. Mshelbwala, Daniel W. Hugenberg, Rolf P. Kreutz

Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study

  • Open Access

Jan Stratmann, Josephine-Nana Ward, Wolfgang Miesbach

Point-of-care testing of coagulation in patients treated with edoxaban

  • Open Access

Florian Härtig, Ingvild Birschmann, Andreas Peter, Sebastian Hörber, Matthias Ebner, Matthias Sonnleitner, Charlotte Spencer, Paula Bombach, Maria-Ioanna Stefanou, Joachim Kuhn, Annerose Mengel, Ulf Ziemann, Sven Poli

Cardiovascular risk factor in MPN patients

  • Letter to the Editor

Vincenzo Accurso, Marco Santoro, Salvatirce Mancuso, Sergio Siragusa

Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation

Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Thomas Schiano, John Mascarenhas

DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis

V. Mai, V. F. Tanguay, C. A. Guay, L. Bertoletti, S. Magnan, A. F. Turgeon, Y. Lacasse, J. C. Lega, S. Provencher

Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation

Marco Toselli, Davide Bosi, Giorgio Benatti, Emilia Solinas, Maria Alberta Cattabiani, Luigi Vignali

Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report

Guillaume Roberge, Tobias Tritschler, Caleb MacGillivray, Laurence Dufresne, Sudhir Kumar Nagpal, Dimitrios Scarvelis

Identification and characterization of a novel variant in C-terminal region of Antithrombin (Ala427Thr) associated with type II AT deficiency leading to polymer formation

Teena Bhakuni, Amit Sharma, Arijit Biswas, Shadabi Bano, Manoranjan Mahapatra, Renu Saxena, Mohamad Aman Jairajpuri

Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management

Andrés Moret, Ángel Zúñiga, Javier Marco Ayala, Alessandro Liquori, Ana Rosa Cid, Saturnino Haya, Fernando Ferrando, Amando Blanquer, José Cervera, Santiago Bonanad

Anemone study: prevalence of risk factors for superficial vein thrombosis in a large Italian population of blood donors

Elvira Grandone, Giovanni Luca Tiscia, Angelo Ostuni, Lazzaro di Mauro, Mario Mastroianno, Nadia Coffetti, Roberto Dovigo, Giovanna Meneghini, Anna Turrini, Giobatta Cavallero, Filomena Cappucci, Patrizia Vergura, Antonio De Laurenzo, Alberto Tosetto, Maurizio Margaglione

Barriers and facilitators to optimal oral anticoagulant management: a scoping review

Mei Wang, Anne Holbrook, Munil Lee, Jiayu Liu, Alvin Leenus, Nora Chen, Lawrence Mbuagbaw, Lehana Thabane

Implementation and impact of a multidisciplinary coagulation factor stewardship program at an academic medical center

  • Letter to the Editor

Anem Waheed, Justin Fongemie, Srila Gopal, Kimberly S. Esham, Leslie Richardson-Weber, Lulu Zhang, Layla Van Doren, Rachel J. Buchsbaum, Raymond L. Comenzo

Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants

Alessandra Serrao, Benedetta Lucani, Giovanni Assanto Manfredi, Luciano Fiori, Erminia Baldacci, Simona Michela Aprile, Antonio Chistolini

Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis

Grace K. H. Lee, Vanessa H. Chen, Choon-Han Tan, Aloysius S. T. Leow, Wan-Yee Kong, Ching-Hui Sia, Nicholas W. S. Chew, Tian-Ming Tu, Bernard P. L. Chan, Leonard L. L. Yeo, Vijay K. Sharma, Benjamin Y. Q. Tan

National trends in tranexamic acid use in the peripartum period, 2015–2019

Homa K. Ahmadzia, Elaine B. Hynds, Richard L. Amdur, Alexis C. Gimovsky, Andra H. James, Naomi L. C. Luban

Heart failure patients have enhanced cerebral autoregulation response in acute ischemic stroke

Pedro Castro, Jorge Serrador, Isabel Rocha, Paulo Castro Chaves, Farzaneh Sorond, Elsa Azevedo

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Podcast

Magendarminfekte: Dos and Don'ts bei Kleinkindern

Die Leitlinie zur akuten infektiösen Gastroenteritis wurde 2024 umfassend überarbeitet. Cola und Saft zur oralen Hydratation und einige Antidiarrhoika sollten vermieden werden. Von einem standardmäßigen Erregerpanel wird abgeraten. Die Hintergründe zu diesen und weiteren Empfehlungen erläutert Leitlinienkoordinator Prof. Carsten Posovszky.

Körperlich fitte Krebskranke leben länger

Krebspatienten, auch und vor allem solche in fortgeschrittenen Stadien, profitieren offenbar von guter körperlicher Verfassung. Hohe Muskelkraft und kardiorespiratorische Fitness sind laut Ergebnissen einer Metaanalyse mit geringerer Mortalität assoziiert.

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

HCL-Systeme bei Typ-1-Diabetes: Blutzuckerkontrolle besser, Risiko für Ketoazidose aber höher

Eine bessere Blutzuckerkontrolle und weniger Fälle von hypoglykämischem Koma, dafür mehr diabetische Ketoazidosen. Dieses HCL-Insulin-Therapie-Profil zeigte sich in einem Vergleich von Hybrid-Closed-Loop(HCL)- und Open-Loop-Systemen bei Typ-I-Diabetes im DPV-Register.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.